M

Medicines Evaluation Unit | Manchester, England

Research site

(Unclaimed)

Location

Langley Building Southmoor Road, Manchester, Manchester, England

Site insights

Top conditions

Top treatments

RPL554

Glycopyrrolate

Tiotropium

Formoterol

PTI-428

Budesonide

CHF1535

CHF6001

ABY-035

Charcoal

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 66 total trials

A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD

The purpose of this study is to assess the efficacy and safety of verekitug (UPB-101) in participants with moderate-to-severe Chronic Obstructive Pul...

Enrolling

Chronic Obstructive Pulmonary Disease

Other: Placebo

Drug: Verekitug

A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD

This study is testing the safety, tolerability, pharmacokinetics and pharmacodynamics of GB-0895.

Active, not recruiting

Asthma

COPD (Chronic Obstructive Pulmonary Disease)

Biological: GB-0895 (SC)

Drug: Placebo (SC)

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis

The aim of this clinical trial is to assess the safety of:* single doses of the study drug CHF6333 in Healthy Volunteers (HVs) and in subjects with B...

Enrolling

Bronchiectasis

Drug: CHF6333 Placebo

Drug: CHF6333

NAL ER IPF Respiratory Function and Safety Study

The primary purpose of this study is to assess the safety and tolerability of escalating doses of NAL ER and to evaluate its effect on respiratory fu...

Enrolling

Idiopathic Pulmonary Fibrosis

Drug: Placebo

Drug: NAL ER